INS and metabolic dysfunction-associated steatotic liver disease: With regards to obesity and type 2 diabetes-associated NAFLD, insulin resistance in adipose tissue hinders insulin-mediated suppression of lipolysis and, thus, increases the levels of serum free fatty acids (FFA)8.